Thermo fisher scientific to acquire corevitas

Waltham, mass.--(business wire)--thermo fisher scientific inc. (nyse: tmo) (“thermo fisher”), the world leader in serving science, today announced it has entered into a definitive agreement to acquire corevitas, llc (“corevitas”), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from audax private equity (“audax”), for $912.5 million in cash. real-world evidence is the collection and use of patient health outcomes data gathered through r.
TMO Ratings Summary
TMO Quant Ranking